Dirk Gouge, DO
Orthopaedic Surgery · Port Angeles, WANPI 1962407551
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,310 of the $3,370 with a category attached, or 68.5%. Smith+Nephew accounts for 97.1% of it on its own, with 3 other manufacturers making up the rest. 2024 is the largest year on record at $2,292, 4.8 times the $481 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in WA, where the typical reported total is $2,959.
Across 24 payments — averaging $140.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Heron Therapeutics, Inc.$66
- Sanara Medtech Inc.$20
- Orthalign Inc$14
What the payments were for
- Travel & lodging$2,31069%
- Food & beverage$1,06031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 21 | $3,271 |
| Heron Therapeutics, Inc. | 1 | $66 |
| Sanara Medtech Inc. | 1 | $20 |
| Orthalign Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,375
- Legion Revision$1,700
- OR3O Dual Mobility$1,358
- RI.HIP NAVIGATION$1,358
- JOURNEY$1,358
- Journey II BCS$580
- Navio Surgical System$339
- NAVIO$241
How this compares
$3,370 in reported general payments places this provider in the 50th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 56 | $396 |
| Gabapentin | 15 | $81 |
| Meloxicam | 31 | $72 |
| Amoxicillin | 30 | $23 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Port Angeles
- William BarrettRenton$7.7M
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.5M
- Burt YaszaySeattle$1.3M
- Sean ToomeySeattle$1.2M
- Richard WilliamsonMount Vernon$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.